myLoop in every stage of life
myLoop – tailored care for every stage of life
Discover how myLoop, powered by CamAPS FX, effectively manages a higher day-to-day variation of insulin needs in very young children with type 1 diabetes and how it best manages glycemic management in young children, adolescents, adults and seniors.
Very young children
Managing Type 1 Diabetes in Very Young Children - A Closer Look
Very young children with type 1 diabetes present unique challenges in daily management. Unpredictable eating habits, fluctuating insulin needs, and highly variable activity levels demand tailored strategies and clinical insight.
Explore how myLoop powered by CamAPS FX can support care in early childhood. Gain practical guidance and expert insight to navigate these complexities with confidence.
Watch now and deepen your understanding of myLoop in very young children.
Specific Challenges
Specific Challenges in Very Young Children with Type 1 Diabetes
Support Better Outcomes
Support Better Outcomes: Achieve Treatment Goals in Very Young Children with myLoop
Clinical Recommendations
myLoop for Very Young Children - Clinical Recommendations & Settings for Optimal Use
Clinical Guidance
myLoop for Very Young Children - Clinical Guidance for Meal Optimisation
Managing Late Evening Rise
Managing Late Evening Rise in Very Young Children using myLoop
myLoop
myLoop - Optimizing Diabetes Management in Young Children with the Personal Glucose Target
Managing Type 1 Diabetes
Managing Type 1 Diabetes in Very Young Children – Clinical Evidence with myLoop powered by CamAPS FX
Clinical Insights: myLoop for very young children
myLoop - the proven solution for type 1 diabetes in very young children.
myLoop for long-term T1D care in young children
Long-term data show that myLoop powered by CamAPS FX improves glycemic management in very young children with T1D by increasing time in range, lowering HbA1c and maintaining safety.
Optimizing myLoop for very young children
Recommended settings for CamAPS FX in very young children, providing guidance for clinical practice.
Optimizing myLoop for very young children
myLoop powered by CamAPS FX in very young children with type 1 diabetes. A detailed overview of the challenges and recommended settings for CamAPS FX in very young children, offering practical guidance for clinical use.
For Adolescents
myLoop – Tailored Care for every stage of Life in Children and Adolescents.
Insulin pumps and Automated Insulin Delivery (AID) systems can significantly improve glucose management, but they do not eliminate the risk of diabetic ketoacidosis (DKA). Because these systems use only rapid-acting insulin, any interruption in insulin delivery (e.g., infusion set failure, pump occlusion, empty reservoir, or device malfunction) can quickly lead to ketosis and DKA — even if glucose levels are not very high. DKA is a serious and potentially life-threatening condition.
If you feel unwell, have persistent high glucose levels, or detect positive ketones, please contact your diabetes care team immediately and follow their guidance. Do not rely solely on the AID system to correct high glucose or clear ketones. Always confirm that insulin is being delivered, and use your backup insulin method (e.g., insulin injections or insulin pens) if needed.
Medical advice can only be provided by healthcare professionals. The information in this material is intended for general educational purposes and should not be interpreted as medical advice or used as a substitute for consultation with a qualified healthcare professional.